| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Updates on global epidemiology, risk and prognostic factors of gastric cancer
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Wen-Juan Yang, He-Ping Zhao, Yan Yu, Ji-Han Wang, Lei Guo, Jun-Ye Liu, Jie Pu and Jing Lv |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Xi'an Municipal Health Commission of China |
2022qn07 |
| Xi'an Municipal Health Commission of China |
2020ms14 |
| Shaanxi Natural Science Foundation of China |
2019JQ-978 |
|
| Corresponding Author |
Jing Lv, MD, Doctor, Doctor, Department of Clinical Laboratory, Honghui Hospital, Xi'an Jiaotong University, No. 555 Youyi Dong Road, Xi'an 710054, Shaanxi Province, China. lvjing-1219@163.com |
| Key Words |
Gastric cancer; Epidemiology; Risk factors; Prognosis; Treatment; Immunotherapy |
| Core Tip |
As a malignant disease with decreasing trends in incidence and mortality, gastric cancer (GC) remains a public health issue worldwide. Various risk factors have been suggested, and the prognosis of GC is related to various factors, such as tumor location, lymph node metastasis, gene polymorphisms and therapeutic strategies. Therefore, novel treatments have been proposed, and immunotherapy has attracted more attention. The present review discusses the epidemiology, risk and prognostic factors of GC with a focus on immunotherapy to better inform the management of GC patients. |
| Publish Date |
2023-04-24 11:14 |
| Citation |
Yang WJ, Zhao HP, Yu Y, Wang JH, Guo L, Liu JY, Pu J, Lv J. Updates on global epidemiology, risk and prognostic factors of gastric cancer. World J Gastroenterol 2023; 29(16): 2452-2468 |
| URL |
https://www.wjgnet.com/1007-9327/full/v29/i16/2452.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v29.i16.2452 |
